Observational analysis shows reduced non-tuberculous mycobacteria infection risk in diabetes with good glycemic control, indicating potential benefits of SGLT2 inhibitors.
SGLT2i use was less associated with NTM infection. In addition, adequate management of co-morbidities and good glycemic control to avoid complications were also associated with reduced risk of NTM infection.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: